We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
News

Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence

Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence
News

Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Exiqon A/S has announced that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence. ICCB-L supports investigators at Harvard Medical School, and associated hospitals and institutions, for high-throughput screening of small molecule and RNAi libraries.

ICCB-L will provide the Exiqon LNA™ microRNA Knockdown Library as a screening tool for a new consortium of Harvard-affiliated investigators, coordinated by Dr. Neil Kubica of the Blenis Laboratory at Harvard Medical School.

The consortium has developed multiple biological models that will be interrogated with the Knockdown Library. The Library contains over 900 specific inhibitors designed for uniform potency, made possible through the incorporation of Exiqon's proprietary LNA™ technology.

"My colleagues and I look forward to screening the Knockdown Library. There is a great deal of interest in our community in using miRNA knockdown reagents to study disease-related biology," says Dr. Kubica.

Exiqon recently unveiled its microRNA Centers of Excellence Program - which has categories for microRNA Profiling (Expression), microRNA detection and imaging (Localization), and microRNA functional studies (Screening) - to help provide a set of reference laboratories and institutions for researchers new to the field of microRNA study.

"More and more researchers are recognizing the importance and relevance of microRNA in their own biological systems under study. But with a variety of methods and solutions from different providers, sometimes researchers aren't sure where to start. It can be overwhelming," says Tom Bishop, Site Director for Exiqon North America. "The microRNA Centers of Excellence are meant to be a roadmap of sorts for researchers new to microRNA - a panel of experts who demonstrate best-in-class tactics and approaches to microRNA studies."

The microRNA Centers of Excellence Program serves as an example of the collaborative spirit in which microRNA research has blossomed over recent years, according to Exiqon officials.

ICCB-L represents the first institution to be inducted as an Exiqon microRNA Center of Excellence, in the area of functional studies. Exiqon is currently accepting other Center of Excellence applications in all categories.
Advertisement